EndoC-βH1 — PKBSM5212UTHG
Summary
EndoC-βH1 cell line, Homo sapiens treated with 1000 U/mL Tumor necrosis factor for 86400 seconds, grown in DMEM containing 5.6 mmol/L glucose, 2% BSA fraction V, fatty acid free, 50 μmol/L 2-mercaptoethanol, 10 mmol/L nicotinamide, 5.5 μg/mL transferrin, 6.7 ng/mL selenite, 100U/mL penicillin + 100 μg/mL streptomycin
Sample Terms
Sources
Sample Name
EndoC-bH1
Classifications
human beta cell line
Growth Medium
DMEM containing 5.6 mmol/L glucose, 2% BSA fraction V, fatty acid free, 50 μmol/L 2-mercaptoethanol, 10 mmol/L nicotinamide, 5.5 μg/mL transferrin, 6.7 ng/mL selenite, 100U/mL penicillin + 100 μg/mL streptomycin
Authentication
not provided
Age
unknown
Coating Condition
Matrigel-fibronectin
Taxa
Homo sapiens
Description
EndoC-bH1 cells treated with TNFa for 24hr from GSE235683
Publication Identifiers
Treatments
1 item
Term Name
Purpose
Type
Summary
stimulation
protein
Treatment of 1000 U/mL Tumor necrosis factor for 86400 seconds
Attribution
Funding
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
